ADMA Biologics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2830 www.admabiologics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics, Inc.

Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Sep 11th, 2026 3:45 pm
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Sep 10th, 2026 3:50 pm
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - Sep 8th, 2026 7:30 am
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound? - Sep 4th, 2026 9:30 am
ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness - Aug 6th, 2026 8:50 am
ADMA Biologics Inc (ADMA) (Q2 2026) Earnings Call Highlights: Ascentiv Surges 24% as Gross ... - Aug 5th, 2026 11:09 pm
ADMA Biologics Q2 Earnings Call Highlights - Aug 5th, 2026 4:03 pm
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:05 pm
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - Jul 31st, 2026 3:45 pm
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? - Jul 29th, 2026 7:30 am
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026 - Jul 29th, 2026 5:00 am
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts - Jul 27th, 2026 3:50 pm
ADMA Biologics (ADMA) Faces Class Actions And Probes Over Revenue Allegations - Jul 15th, 2026 12:13 pm
ADMA Biologics (ADMA) Stock Looks Undervalued Even After A 5 Year Run - Jul 15th, 2026 1:16 am